Serum Zinc Level Grading System: A Useful Model for Composite Hepatic Events in Hepatitis C Virus-Associated Liver Cirrhosis.

ALBI grade Child–Pugh classification classification system composite hepatic events liver cirrhosis serum zinc

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
28 Feb 2020
Historique:
received: 03 02 2020
revised: 19 02 2020
accepted: 27 02 2020
entrez: 4 3 2020
pubmed: 4 3 2020
medline: 4 3 2020
Statut: epublish

Résumé

We aimed to clarify the impact of the serum zinc (Zn) level grading system proposed by the Japanese society of clinical nutrition (JSCN: 80 μg/dL < serum Zn level <130 μg/dL (type A), 60 μg/dL < serum Zn level <80 μg/dL (type B), and serum Zn level <60 μg/dL (type C)) in patients with hepatitis C virus (HCV)-related liver cirrhosis (LC) on the incidence of composite hepatic events (Com-HEs) compared with Child-Pugh (C-P) classification or albumin-bilirubin (ALBI) grade. (n = 275, median age = 67 years). The Akaike information criterion (AIC) was compared among three prognostic models. Factors associated with the incidence of Com-HEs were also studied. The first incidence of any HE was confirmed in 112 patients (40.7%). The AIC value for Com-HEs by the Zn level grading system was the lowest among the three prognostic models (AIC: 301.788 in Zn level grading system, 303.372 in ALBI grade, and 333.953 in C-P classification). In the multivariate analysis, male (

Identifiants

pubmed: 32121095
pii: jcm9030643
doi: 10.3390/jcm9030643
pmc: PMC7141206
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Dig Dis Sci. 2007 Jul;52(7):1595-612
pubmed: 17415640
Am J Physiol. 1986 Aug;251(2 Pt 2):R398-408
pubmed: 3740321
J Hepatol. 2011 Apr;54(4):650-9
pubmed: 21146892
J Hepatol. 2018 Aug;69(2):406-460
pubmed: 29653741
Lancet. 2019 Oct 12;394(10206):1335-1343
pubmed: 31492505
Clin Gastroenterol Hepatol. 2005 Jul;3(7):705-13
pubmed: 16206505
Hepatology. 2002 Nov;36(5 Suppl 1):S3-20
pubmed: 12407572
BMJ. 2010 Aug 18;341:c3920
pubmed: 20719825
Lancet. 2014 May 17;383(9930):1749-61
pubmed: 24480518
N Engl J Med. 2016 Aug 25;375(8):767-77
pubmed: 27557303
Hepatol Res. 2019 Jul;49(7):731-742
pubmed: 30892804
Br J Surg. 1973 Aug;60(8):646-9
pubmed: 4541913
Medicine (Baltimore). 2020 Jan;99(1):e18632
pubmed: 31895823
Hum Pathol. 2016 Sep;55:63-71
pubmed: 27189343
Hepatol Res. 2010 Jan;40(1):8-13
pubmed: 20156296
Hepatol Res. 2019 Oct;49(10):1127-1135
pubmed: 31240767
PLoS One. 2018 Dec 12;13(12):e0208903
pubmed: 30540824
Viruses. 2018 Oct 06;10(10):
pubmed: 30301201
J Virol. 1997 Apr;71(4):2881-6
pubmed: 9060645
J Gastroenterol. 2016 Jul;51(7):629-50
pubmed: 27246107
J Clin Med. 2019 Nov 22;8(12):
pubmed: 31766742
Hepatol Int. 2017 Jul;11(4):317-370
pubmed: 28620797
Gastroenterology. 2005 Nov;129(5):1464-72
pubmed: 16285948
J Clin Oncol. 2015 Feb 20;33(6):550-8
pubmed: 25512453
World J Gastroenterol. 2016 Mar 7;22(9):2844-54
pubmed: 26973423
J Clin Med. 2019 Jun 01;8(6):
pubmed: 31159435
Hepatol Res. 2015 Jan;45(1):59-74
pubmed: 24965914
J Biol Chem. 2004 Nov 19;279(47):48576-87
pubmed: 15339921
J Hepatol. 2012 Jan;56(1):55-62
pubmed: 21781944
Gastroenterology. 2019 Jan;156(2):446-460.e2
pubmed: 30367836
Br J Cancer. 2016 Mar 29;114(7):744-50
pubmed: 27022825
Hepatol Res. 2019 Oct;49(10):1109-1113
pubmed: 31336394
Intervirology. 2008;51 Suppl 1:17-26
pubmed: 18544944
J Gastroenterol Hepatol. 2016 May;31(5):1031-6
pubmed: 26647219
Lancet. 2019 Nov 2;394(10209):1619-1628
pubmed: 31570258
Lancet. 2019 Oct 5;394(10205):1243-1253
pubmed: 31488372
Dig Liver Dis. 2019 Aug;51(8):1172-1178
pubmed: 30765220
Recenti Prog Med. 2018 Dec;109(12):605-608
pubmed: 30667391
Hepatol Res. 2019 Nov;49(11):1353-1356
pubmed: 31313881
Dig Dis Sci. 2006 Nov;51(11):1967-77
pubmed: 17048113
Liver Int. 2016 Dec;36(12):1821-1828
pubmed: 27214151
World J Gastroenterol. 2012 Jul 7;18(25):3196-200
pubmed: 22783042
Br J Surg. 2016 May;103(6):725-734
pubmed: 27005482
J Hepatol. 2018 Oct;69(4):793-802
pubmed: 29758335
Curr Treat Options Gastroenterol. 2016 Jun;14(2):257-73
pubmed: 27023701
Nutr J. 2013 Jun 06;12:74
pubmed: 23742732
Nutrients. 2018 Jul 27;10(8):
pubmed: 30060473

Auteurs

Hiroki Nishikawa (H)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.
Center for clinical research and education, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Hirayuki Enomoto (H)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Kazunori Yoh (K)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Yoshinori Iwata (Y)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Yoshiyuki Sakai (Y)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Kyohei Kishino (K)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Yoshihiro Shimono (Y)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Naoto Ikeda (N)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Tomoyuki Takashima (T)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Nobuhiro Aizawa (N)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Ryo Takata (R)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Kunihiro Hasegawa (K)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Noriko Ishii (N)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Yukihisa Yuri (Y)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Takashi Nishimura (T)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Hiroko Iijima (H)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Shuhei Nishiguchi (S)

Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan.

Classifications MeSH